Literature DB >> 8415751

Hematopoietic stem-cell defects underlying abnormal macrophage development and maturation in NOD/Lt mice: defective regulation of cytokine receptors and protein kinase C.

D V Serreze1, J W Gaedeke, E H Leiter.   

Abstract

The immunopathogenesis of autoimmune insulin-dependent diabetes in NOD mice entails defects in the development of macrophages (M phi s) from hematopoietic precursors. The present study analyzes the cellular and molecular basis underlying our previous finding that the Mø growth factor colony-stimulating factor 1 (CSF-1) promotes a reduced level of promonocyte proliferation and M phi development from NOD bone marrow. CSF-1 stimulation of NOD marrow induced Møs to differentiate to the point that they secreted levels of tumor necrosis factor alpha equivalent to that of controls. However, CSF-1 failed to prime NOD M phi s to completely differentiate in response to gamma-interferon, as shown by their decreased lipopolysaccharide-stimulated interleukin 1 secretion. These defects, in turn, were associated with an inability of CSF-1 to up-regulate c-fms (CSF-1 receptor) and Ifgr (gamma-interferon receptor) expression. Even though the combination of CSF-1 and gamma-interferon up-regulated c-fms and Ifgr transcript levels in NOD M phi s to levels induced in control M phi s by CSF-1 alone, the protein kinase C activities coupled to these receptors remained 4-fold lower in NOD M phi s than in M phi s derived from the marrow of diabetes-resistant NON and SWR control mice. Despite expressing the diabetogenic H-2g7 haplotype, M phi s derived from cytokine-stimulated marrow of the NON.H-2g7 congenic stock were functionally more mature than similarly derived M phi s from NOD mice. Whereas diabetes resistance was abrogated in 67% of irradiated (NOD x NON)F1 females reconstituted with NOD marrow, no recipients became diabetic after reconstitution with a 1:1 mixture of marrow from NOD and the congenic stock. Thus, failure to develop functionally mature monocytes may be of pathogenic significance in NOD mice.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8415751      PMCID: PMC47622          DOI: 10.1073/pnas.90.20.9625

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  38 in total

1.  Functional analysis of cloned macrophage hybridomas. VII. Modulation of suppressor T cell-inducing activity.

Authors:  H Ishikura; S Jayaraman; V Kuchroo; B Diamond; S Saito; M E Dorf
Journal:  J Immunol       Date:  1989-07-15       Impact factor: 5.422

2.  Macrophage heterogeneity occurs through a developmental mechanism.

Authors:  A L Witsell; L B Schook
Journal:  Proc Natl Acad Sci U S A       Date:  1991-03-01       Impact factor: 11.205

3.  Comparison of cytokine effects on mouse pancreatic alpha-cell and beta-cell lines. Viability, secretory function, and MHC antigen expression.

Authors:  K Hamaguchi; E H Leiter
Journal:  Diabetes       Date:  1990-04       Impact factor: 9.461

4.  Genetic control of diabetogenesis in NOD/Lt mice. Development and analysis of congenic stocks.

Authors:  M Prochazka; D V Serreze; S M Worthen; E H Leiter
Journal:  Diabetes       Date:  1989-11       Impact factor: 9.461

5.  Genetic mapping of the mouse c-fms proto-oncogene to chromosome 18.

Authors:  M D Hoggan; N F Halden; C E Buckler; C A Kozak
Journal:  J Virol       Date:  1988-03       Impact factor: 5.103

6.  Prevention of diabetes in nonobese diabetic mice by tumor necrosis factor (TNF): similarities between TNF-alpha and interleukin 1.

Authors:  C O Jacob; S Aiso; S A Michie; H O McDevitt; H Acha-Orbea
Journal:  Proc Natl Acad Sci U S A       Date:  1990-02       Impact factor: 11.205

7.  Distinction between immunogenicity and tolerogenicity among HBcAg T cell determinants. Influence of peptide-MHC interaction.

Authors:  D R Milich; J E Jones; A McLachlan; R Houghten; G B Thornton; J L Hughes
Journal:  J Immunol       Date:  1989-11-15       Impact factor: 5.422

8.  Prevention of type I diabetes in NOD mice by adjuvant immunotherapy.

Authors:  M W Sadelain; H Y Qin; J Lauzon; B Singh
Journal:  Diabetes       Date:  1990-05       Impact factor: 9.461

9.  Molecular genetic markers spanning mouse chromosome 10.

Authors:  C A Kozak; M Peyser; M Krall; T M Mariano; C S Kumar; S Pestka; B A Mock
Journal:  Genomics       Date:  1990-11       Impact factor: 5.736

10.  Colony-stimulating factor 1 activates protein kinase C in human monocytes.

Authors:  K Imamura; A Dianoux; T Nakamura; D Kufe
Journal:  EMBO J       Date:  1990-08       Impact factor: 11.598

View more
  41 in total

1.  A defect in bone marrow derived dendritic cell maturation in the nonobesediabetic mouse.

Authors:  J Strid; L Lopes; J Marcinkiewicz; L Petrovska; B Nowak; B M Chain; T Lund
Journal:  Clin Exp Immunol       Date:  2001-03       Impact factor: 4.330

Review 2.  Prospects for the prevention and reversal of type 1 diabetes mellitus.

Authors:  Nikolai Petrovsky; Diego Silva; Desmond A Schatz
Journal:  Drugs       Date:  2002       Impact factor: 9.546

Review 3.  Resolving the conundrum of islet transplantation by linking metabolic dysregulation, inflammation, and immune regulation.

Authors:  Xiaolun Huang; Daniel J Moore; Robert J Ketchum; Craig S Nunemaker; Boris Kovatchev; Anthony L McCall; Kenneth L Brayman
Journal:  Endocr Rev       Date:  2008-07-29       Impact factor: 19.871

4.  Macrophage cell lines derived from major histocompatibility complex II-negative mice.

Authors:  A A Beharka; J W Armstrong; S K Chapes
Journal:  In Vitro Cell Dev Biol Anim       Date:  1998-06       Impact factor: 2.416

5.  Cardiovascular adaptations of pregnancy in T and B cell-deficient mice.

Authors:  Suzanne D Burke; Valérie F Barrette; Alexandra L Carter; Jonathan Gravel; Michael A Adams; B Anne Croy
Journal:  Biol Reprod       Date:  2011-05-25       Impact factor: 4.285

Review 6.  The role of interleukin-1 in the pathogenesis of IDDM.

Authors:  T Mandrup-Poulsen
Journal:  Diabetologia       Date:  1996-09       Impact factor: 10.122

7.  Experimental infection of immunomodulated NOD/LtSz-SCID mice as a new model for Plasmodium falciparum erythrocytic stages.

Authors:  Alicia Moreno Sabater; Marta Moreno; Francisco Javier Moreno; Cesar Eguiluz; Nico van Rooijen; Agustin Benito
Journal:  Parasitol Res       Date:  2004-12-10       Impact factor: 2.289

Review 8.  Anti-diabetic functions of soy isoflavone genistein: mechanisms underlying its effects on pancreatic β-cell function.

Authors:  Elizabeth R Gilbert; Dongmin Liu
Journal:  Food Funct       Date:  2013-02       Impact factor: 5.396

Review 9.  Vitamin D and human health: lessons from vitamin D receptor null mice.

Authors:  Roger Bouillon; Geert Carmeliet; Lieve Verlinden; Evelyne van Etten; Annemieke Verstuyf; Hilary F Luderer; Liesbet Lieben; Chantal Mathieu; Marie Demay
Journal:  Endocr Rev       Date:  2008-08-11       Impact factor: 19.871

10.  Therapy of experimental type 1 diabetes by isolated Sertoli cell xenografts alone.

Authors:  Francesca Fallarino; Giovanni Luca; Mario Calvitti; Francesca Mancuso; Claudio Nastruzzi; Maria C Fioretti; Ursula Grohmann; Ennio Becchetti; Anne Burgevin; Roland Kratzer; Peter van Endert; Louis Boon; Paolo Puccetti; Riccardo Calafiore
Journal:  J Exp Med       Date:  2009-10-12       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.